STJ  St. Jude Medical Inc.

Exchange

NYSE

Sector

Health Care

Industry

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Market Cap.

20.96B

Vuru Grade

66.32/100

Current Price

$73.43
-0.39 (-0.53%)

Growth Price

$53.43
Overvalued by 27.24%

Stability Price

$20.29
Overvalued by 72.37%

Company Metrics

  • 20.47 P/E
  • 3.79 P/S
  • 5.49 P/B
  • 3.59 EPS
  • 14.54% Cash ROIC
  • 0.54 Cash Ratio
  • 1.16 / 1.6% Dividend
  • 1.41M Avg. Vol.
  • 285.44M Shares
  • 20.96B Market Cap.

Company Description

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantab...
more


Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow

News

St Jude Medical Inc (STJ) Discloses Form 4 Insider Selling : Exec. Daniel J ...
American Trade Journal - 13 hours ago
St Jude Medical Inc (STJ) Discloses Insider Transaction. Daniel J Starks , Chairman, CEO & President of St Jude Medical Inc sold 100,000 shares on Jul 29, 2015. The Insider selling transaction was disclosed on Jul 31, 2015 to the Securities and ...
St. Jude Medical (STJ) - Research Analysts' Recent Ratings Changes - Dakota Financial News
Value Stock Watch: St. Jude Medical, Inc. (NYSE:STJ) - Enterprise Leader
St. Jude Medical to Buy Thoratec for $3.4 Billion
Wall Street Journal - Jul 22, 2015
St. Jude is aiming to expand its portfolio of devices for the treatment of heart failure, a condition affecting some six million people in the U.S.
St. Jude to buy California heart device company for $3.4 billion - Minneapolis Star Tribune
St. Jude Medical to Expand Heart-Device Business - Morningstar.com
BMO Capital Downgrades St. Jude Medical On 'Less Compelling' Risk/Reward
Benzinga - Jul 23, 2015
In a report published Thursday, BMO Capital Markets analyst Joanne Wuensch downgraded the rating on St. Jude Medical, Inc. (NYSE: STJ) from Outperform to Market Perform, while raising the price target from $80 to $81. St. Jude reported its 2Q15 results ...
St. Jude Medical (STJ) Stock Downgraded at Deutsche Bank, BMO Capital - TheStreet.com
St. Jude Medical Inc Expands Portfolio of Medical Devices that Aids Heart Failure - Franchise Herald
New Lifetime High Reached By St Jude Medical (STJ)
TheStreet.com - Jul 14, 2015
St. Jude Medical, Inc., together with its subsidiaries, develops, manufactures and distributes cardiovascular medical devices for cardiac rhythm management, cardiovascular, and atrial fibrillation therapy areas worldwide.
Large Outflow of Money Witnessed in St. Jude Medical, Inc. - Insider Trading Report
Short Interest Update of St. Jude Medical, Inc. (NYSE:STJ) - Money Flow Index
Zacks Rating on St. Jude Medical, Inc.
Money Flow Index - Jul 30, 2015
St. Jude Medical, Inc. (NYSE:STJ): The mean short term price target for St. Jude Medical, Inc. (NYSE:STJ) has been established at $81.53 per share. The higher price target estimate is at $91 and the lower price target estimate is expected at $64 ...
What after Daniel Starks's Insider Sale of St. Jude Medical, Inc. (NYSE:STJ ...
OctaFinance.com - Jul 31, 2015
St. Jude Medical, Inc. (NYSE:STJ) 73.84 -0.07 -0.09% Chairman - CEO & President Daniel Starks on the 31/07/2015 unloaded a total of 100,000 shares of the Minnesota-based company valued by the market at approximately $7,393,000 U.S.
St. Jude Medicals Penta Paddle Lead Labeling Gets FDA Nod
Zacks.com - Jul 21, 2015
In May, the company completed its acquisition of Spinal Modulation, Inc. - developer of the Axium Neurostimulator System.
General Report on St Jude Medical Inc (NYSE:STJ) - Street Report
St. Jude Medical's Penta Paddle Lead Labeling Gets FDA Nod - Analyst Blog - Nasdaq
St. Jude Medicals Invisible Trial System Gets FDA Approval
Zacks.com - Jul 17, 2015
In May, the company completed its acquisition of Spinal Modulation, Inc. - developer of the Axium Neurostimulator System.
St. Jude Medical Receives FDA Approval for the Industry's First Spinal Cord ... - MarketWatch
Whats in Store for St. Jude Medical (STJ) in Q2 Earnings?
Zacks.com - Jul 20, 2015
St. Jude Medical Inc. (STJ - Analyst Report) is slated to release its second-quarter 2015 earnings results on Jul 22.
St. Jude Medical adds more heart devices in $3.4B buy
Valdosta Daily Times - Jul 22, 2015
The deal allows St. Jude Medical Inc. access to new markets totaling more than $1 billion that are expected to grow about 10 percent annually, the company said.
St. Jude sees good outlook for Thoratec HeartMate 3 - Minneapolis Star Tribune
THOR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Launches an ... - MarketWatch